Human Genome Epidemiology Literature Finder
Records 1 - 21 (of 21 Records) |
Query Trace: Disease Progression and ESR1[original query] |
---|
Molecular markers in key steroidogenic pathways, circulating steroid levels, and prostate cancer progression. Clinical cancer research : an official journal of the American Association for Cancer Research 2013 Feb 19 (3): 699-709. Lévesque Éric, Huang Shu-Pin, Audet-Walsh Étienne, Lacombe Louis, Bao Bo-Ying, Fradet Yves, Laverdière Isabelle, Rouleau Mélanie, Huang Chao-Yuan, Yu Chia-Cheng, Caron Patrick, Guillemette Chant |
Effects of genetic variation on the dynamics of neurodegeneration in Alzheimer's disease. Annual International Conference of the IEEE Engineering in Medicine and Biology Society. IEEE Engineering in Medicine and Biology Society. Annual International Conference 2014 2014 2464-7. Printy Blake P, Verma Nishant, Cowperthwaite Matthew C, Markey Mia K, |
Detection and Characterization of Circulating Tumor Associated Cells in Metastatic Breast Cancer. International journal of molecular sciences 2016 Sep 17 (10): . Mu Zhaomei, Benali-Furet Naoual, Uzan Georges, Znaty Anaëlle, Ye Zhong, Paolillo Carmela, Wang Chun, Austin Laura, Rossi Giovanna, Fortina Paolo, Yang Hushan, Cristofanilli Massi |
Tracking evolution of aromatase inhibitor resistance with circulating tumour DNA analysis in metastatic breast cancer. Annals of oncology : official journal of the European Society for Medical Oncology 2018 01 29 (1): 145-153. Fribbens C, Garcia Murillas I, Beaney M, Hrebien S, O'Leary B, Kilburn L, Howarth K, Epstein M, Green E, Rosenfeld N, Ring A, Johnston S, Turner |
Breast cancer metastasis to gynaecological organs: a clinico-pathological and molecular profiling study. The journal of pathology. Clinical research 2018 Sep . Kutasovic Jamie R, McCart Reed Amy E, Males Renique, Sim Sarah, Saunus Jodi M, Dalley Andrew, McEvoy Christopher R, Dedina Liana, Miller Gregory, Peyton Stephen, Reid Lynne, Lal Samir, Niland Colleen, Ferguson Kaltin, Fellowes Andrew P, Al-Ejeh Fares, Lakhani Sunil R, Cummings Margaret C, Simpson Peter |
Clinical significance of plasma cell-free DNA mutations in PIK3CA, AKT1, and ESR1 gene according to treatment lines in ER-positive breast cancer. Molecular cancer 2018 Feb 17 (1): 67. Takeshita Takashi, Yamamoto Yutaka, Yamamoto-Ibusuki Mutsuko, Tomiguchi Mai, Sueta Aiko, Murakami Keiichi, Iwase Hirota |
Polymorphisms and endometriosis: a systematic review and meta-analyses. Human reproduction update 2019 12 26 (1): 73-102. Méar Loren, Herr Marie, Fauconnier Arnaud, Pineau Charles, Vialard Franço |
Alterations in PTEN and ESR1 promote clinical resistance to alpelisib plus aromatase inhibitors. Nature cancer 2020 9 1 (4): 382-393. Razavi Pedram, Dickler Maura N, Shah Payal D, Toy Weiyi, Brown David N, Won Helen H, Li Bob T, Shen Ronglai, Vasan Neil, Modi Shanu, Jhaveri Komal, Caravella Betty Ann, Patil Sujata, Selenica Pier, Zamora Stephen, Cowan Aimee M, Comen Elizabeth, Singh Andy, Covey Anne, Berger Michael F, Hudis Clifford A, Norton Larry, Nagy Rebecca J, Odegaard Justin I, Lanman Richard B, Solit David B, Robson Mark E, Lacouture Mario E, Brogi Edi, Reis-Filho Jorge S, Moynahan Mary Ellen, Scaltriti Maurizio, Chandarlapaty Sar |
Expression of oestrogen-? receptor in papillary thyroid carcinoma and its association with metastasis. The Malaysian journal of pathology 2020 12 42 (3): 415-422. Ab Halim S A, Lee S K, Mustangin M, Mohd Saleh M F, Shah S A, Md Isa |
The Use of Serial Circulating Tumor DNA to Detect Resistance Alterations in Progressive Metastatic Breast Cancer. Clinical cancer research : an official journal of the American Association for Cancer Research 2020 Dec . Jacob Saya, Davis Andrew A, Gerratana Lorenzo, Velimirovic Marko, Shah Ami N, Wehbe Firas, Katam Neelima, Zhang Qiang, Flaum Lisa, Siziopikou Kalliopi P, Platanias Leonidas C, Gradishar William J, Behdad Amir, Bardia Aditya, Cristofanilli Massi |
ESR1 Gene Mutation in Hormone Receptor-Positive HER2-Negative Metastatic Breast Cancer Patients: Concordance Between Tumor Tissue and Circulating Tumor DNA Analysis. Frontiers in oncology 2021 11 625636. Urso Loredana, Vernaci Grazia, Carlet Jessica, Lo Mele Marcello, Fassan Matteo, Zulato Elisabetta, Faggioni Giovanni, Menichetti Alice, Di Liso Elisabetta, Griguolo Gaia, Falci Cristina, Conte Pierfranco, Indraccolo Stefano, Guarneri Valentina, Dieci Maria Vittor |
Prognosis and Genomic Landscape of Liver Metastasis in Patients With Breast Cancer. Frontiers in oncology 2021 3 11 588136. Tian Chonglin, Liu Sujing, Wang Yongsheng, Song Xianra |
Shallow WGS of individual CTCs identifies actionable targets for informing treatment decisions in metastatic breast cancer. British journal of cancer 2022 Sep . Fernandez-Garcia Daniel, Nteliopoulos Georgios, Hastings Robert K, Rushton Amelia, Page Karen, Allsopp Rebecca C, Ambasager Bana, Gleason Kelly, Guttery David S, Ali Simak, Charles Coombes R, Shaw Jacqueline |
Identification of mutation patterns and circulating tumour DNA-derived prognostic markers in advanced breast cancer patients. Journal of translational medicine 2022 05 20 (1): 211. Liao Hao, Zhang Jiayang, Zheng Tiantian, Liu Xiaoran, Zhong Jianxin, Shao Bin, Dong Xiaoxi, Wang Xiaohong, Du Pan, King Bonnie L, Jia Shidong, Yu Jianjun, Li Huipi |
Switch to fulvestrant and palbociclib versus no switch in advanced breast cancer with rising ESR1 mutation during aromatase inhibitor and palbociclib therapy (PADA-1): a randomised, open-label, multicentre, phase 3 trial. The Lancet. Oncology 2022 10 23 (11): 1367-1377. Bidard François-Clément, Hardy-Bessard Anne-Claire, Dalenc Florence, Bachelot Thomas, Pierga Jean-Yves, de la Motte Rouge Thibault, Sabatier Renaud, Dubot Coraline, Frenel Jean-Sébastien, Ferrero Jean Marc, Ladoire Sylvain, Levy Christelle, Mouret-Reynier Marie-Ange, Lortholary Alain, Grenier Julien, Chakiba Camille, Stefani Laetitia, Plaza Jérôme Edouard, Clatot Florian, Teixeira Luis, D'Hondt Véronique, Vegas Hélène, Derbel Olfa, Garnier-Tixidre Claire, Canon Jean-Luc, Pistilli Barbara, André Fabrice, Arnould Laurent, Pradines Anne, Bièche Ivan, Callens Céline, Lemonnier Jérôme, Berger Frédérique, Delaloge Suzette, |
Longitudinal multi-omics study of palbociclib resistance in HR-positive/HER2-negative metastatic breast cancer. Genome medicine 2023 7 15 (1): 55. Yeon Hee Park, Seock-Ah Im, Kyunghee Park, Ji Wen, Kyung-Hun Lee, Yoon-La Choi, Won-Chul Lee, Ahrum Min, Vinicius Bonato, Seri Park, Sripad Ram, Dae-Won Lee, Ji-Yeon Kim, Su Kyeong Lee, Won-Woo Lee, Jisook Lee, Miso Kim, Hyun Seon Kim, Scott L Weinrich, Han Suk Ryu, Tae Yong Kim, Stephen Dann, Yu-Jin Kim, Diane R Fernandez, Jiwon Koh, Shuoguo Wang, Song Yi Park, Shibing Deng, Eric Powell, Rupesh Kanchi Ravi, Jadwiga Bienkowska, Paul A Rejto, Woong-Yang Park, Zhengyan K |
Alternating 17?-Estradiol and Aromatase Inhibitor Therapies Is Efficacious in Postmenopausal Women with Advanced Endocrine-Resistant ER+ Breast Cancer. Clinical cancer research : an official journal of the American Association for Cancer Research 2023 6 OF1-OF7. Gary N Schwartz, Peter A Kaufman, Karthik V Giridhar, Jonathan D Marotti, Mary D Chamberlin, Bradley A Arrick, Grace Makari-Judson, Matthew P Goetz, Shannon M Soucy, Fred Kolling, Eugene Demidenko, Todd W Mill |
Design of SERENA-6, a phase III switching trial of camizestrant in ESR1-mutant breast cancer during first-line treatment. Future oncology (London, England) 2023 4 . Nicholas Turner, Cynthia Huang-Bartlett, Kevin Kalinsky, Massimo Cristofanilli, Giampaolo Bianchini, Stephen Chia, Hiroji Iwata, Wolfgang Janni, Cynthia X Ma, Erica L Mayer, Yeon Hee Park, Steven Fox, Xiaochun Liu, Sasha McClain, Francois-Clement Bida |
Changes in cell-free DNA after short-term palbociclib and fulvestrant treatment for advanced or metastatic hormone receptor-positive and human epidermal growth factor 2-negative breast cancer. Breast cancer research and treatment 2023 10 . Takayuki Iwamoto, Naoki Niikura, Kenichi Watanabe, Takashi Takeshita, Yuichiro Kikawa, Kokoro Kobayashi, Nobutaka Iwakuma, Takuho Okamura, Hiroshi Tada, Shinji Ozaki, Toshitaka Okuno, Uhi Toh, Yutaka Yamamoto, Michiko Tsuneizumi, Hiroshi Ishiguro, Norikazu Masuda, Shigehira Sa |
Genomic complexity predicts resistance to endocrine therapy and CDK4/6 inhibition in hormone receptor-positive (HR+)/HER2-negative metastatic breast cancer. Clinical cancer research : an official journal of the American Association for Cancer Research 2023 1 . Davis Andrew A, Luo Jingqin, Zheng Tiantian, Dai Chao, Dong Xiaoxi, Tan Lu, Suresh Rama, Ademuyiwa Foluso O, Rigden Caron, Rearden Timothy P, Clifton Katherine, Weilbaecher Katherine, Frith Ashley, Tandra Pavankumar K, Summa Tracy, Haas Brittney, Thomas Shana, Hernandez-Aya Leonel F, Peterson Lindsay L, Wang Xiaohong, Luo Shujun J, Zhou Kemin, Du Pan, Jia Shidong, King Bonnie L, Krishnamurthy Jairam, Ma Cynthia |
Genomic Landscape of Circulating Tumor DNA in Patients With Hormone Receptor-Positive/Human Epidermal Growth Factor Receptor-2-Negative Metastatic Breast Cancer Treated With Abemaciclib: Data From the SCRUM-Japan Cancer Genome Screening Project. JCO precision oncology 2024 4 8 e2300647. Masaya Hattori, Victoria Serelli-Lee, Yoichi Naito, Takashi Yamanaka, Hiroyuki Yasojima, Rikiya Nakamura, Takao Fujisawa, Mitsuho Imai, Yoshiaki Nakamura, Hideaki Bando, Tsutomu Kawaguchi, Takayuki Yoshino, Hiroji Iwa |
- Page last reviewed:Feb 1, 2024
- Page last updated:May 13, 2024
- Content source: